Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
We have cloned a member of the steroid hormone receptor superfamily of ligand-activated transcription factors. The receptor homologue is activated by a diverse class of rodent hepatocarcinogens that causes proliferation of peroxisomes. Identification of a peroxisome proliferator-activated receptor should help elucidate the mechanism of the hypolipidaemic effect of these hepatocarcinogens and aid evaluation of their potential carcinogenic risk to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After the structure of PPAR was clarified, three PPAR isoforms (PPARα, PPARγ, and PPARδ) have been identified, each of which is encoded by a separate gene [21].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [21]
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs
Kozak, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.20.8125 · Cited by 5,087
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Self-citationA human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
Identification of a receptor for the morphogen retinoic acid
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987) · Nature · doi:10.1038/330624a0 · Cited by 1,965
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
The c-erb-A gene encodes a thyroid hormone receptor
Weinberger, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., & Evans, R. M. (1986) · Nature · doi:10.1038/324641a0 · Cited by 1,477
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Self-citation
Research works printed but not linked: 8
- Reddy, J. K., Rao, M. S., Azarnoff, D. I. & Sell, S. Cancer Res. 39, 152–161 (1979).
- Sirtori, C. R., Catapano, A. & Paoletti, R. Atherosclerosis Rev. 2, 113–153 (1977).
- Warren, J. R., Simmon, V. F. & Reddy, J. K. Cancer Res. 40, 36–41 (1980).
- Kasai, H., Okadi, Y., Nishimura, S., Rao, M. S. & Reddy, J. K. Cancer Res. 49, 2603–2605 (1989).
- Marsman, D. S., Cattley, R. C., Conway, J. G. & Popp, J. A. Cancer Res. 48, 6739–6744 (1988).
- Cattley, R. C. & Popp, J. A. Cancer Res. 49, 3246–3251 (1989).
- Nemali, M. R. et al. Cancer Res. 48, 5316–5324 (1988).
- Current Protocols in Molecular Biology (Wiley, New York, 1990).
Cited by
Items 501–600 of 1,011
Maintaining Ancient Organelles: Mitochondrial Biogenesis and Maturation
Vega, R. B., Horton, J. L., & Kelly, D. P. (2015) · Circulation Research · doi:10.1161/circresaha.116.305420 · Cited by 146
A structural perspective on nuclear receptors as targets of environmental compounds
Delfosse, V., Maire, A. L., Balaguer, P., & Bourguet, W. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.133 · Cited by 136
Biochemistry of peroxisomes in health and disease
Singh, I. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006883229684 · Cited by 158
“The peroxisomal proliferators have been found to activate receptors of the steroid hormone superfamily [69, 70].”
Background9-cis retinoic acid signaling: changing partners causes some excitement.
Leblanc, B. P., & Stunnenberg, H. G. (1995) · Genes & Development · doi:10.1101/gad.9.15.1811 · Cited by 142
From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Pistis, M., & Melis, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980014 · Cited by 142
“-oxidation) of fatty acids, was cloned and denominated peroxisome proliferator-activated receptor[77].”
BackgroundCytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism
Kalsotra, A., & Strobel, H. W. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.008 · Cited by 155
“In a parallel study using PPARα −/− mice, reduction in hepatic Cyp4f16 expression upon clofibrate administration was found to be PPARα independent (Cui et al., 2001).”
BackgroundMethodInfluentialPeroxisome Proliferator‐activated Receptors: Stuctures and Function
TUGWOOD, J. D., ALDRIDGE, T. C., LAMBE, K. G., MACDONALD, N., & WOODYATT, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18620.x · Cited by 148
Crabb, D. W., Galli, A., Fischer, M., & You, M. (2004) · Alcohol · doi:10.1016/j.alcohol.2004.07.005 · Cited by 154
Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator–Activated Receptor α
Park, C. W., Kim, H. W., Ko, S. H., Chung, H. W., Lim, S. W., Yang, C. W., Chang, Y. S., Sugawara, A., Guan, Y., & Breyer, M. D. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1329 · Cited by 144
“Peroxisome proliferator–activated receptor (PPAR) is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors and plays an important role in lipid metabolism (1).”
BackgroundSteineger, H. H., Sørensen, H. N., Tugwood, J. D., Skrede, S., Spydevold, Ø., & Gautvik, K. M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.0967b.x · Cited by 145
Ito, Y., Yamanoshita, O., Asaeda, N., Tagawa, Y., Lee, C., Aoyama, T., Ichihara, G., Furuhashi, K., Kamijima, M., Gonzalez, F. J., et al. (2007) · Journal of Occupational Health · doi:10.1539/joh.49.172 · Cited by 141
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease
Ambrosi, B., Dall'Asta, C., Cannavo, S., Libe, R., Vigo, T., Epaminonda, P., Chiodini, I., Ferrero, S., Trimarchi, F., Arosio, M., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510173 · Cited by 147
“Peroxisome proliferator-activated receptor-g (PPAR-g) is one of the isoforms of the PPAR family of nuclear hormone receptors, and it acts as a transcription factor translating several stimuli to changes in the expression of genes ( 1 , 2). Besides the well-known established effects of thiazolidinediones on adipocyte d…”
BackgroundRegulatory potential of n-3 fatty acids in immunological and inflammatory processes
Grimm, H., Mayer, K., Mayser, P., & Eigenbrodt, E. (2002) · British Journal of Nutrition · doi:10.1079/bjn2001457 · Cited by 143
“The amino acid sequence of PPAR indicated that they possess structural features characteristic of steroid receptors, i.e. a ligand-binding domain and a zinc finger DNA-binding domain (Issemann & Green, 1990).”
BackgroundKarpichev, I. V., & Small, G. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6560 · Cited by 139
“Activation of PPARg by 15-deoxyD12,14-prostaglandin J2 or a synthetic analog promotes differentiation of preadipocytes into fat cells (16), whereas PPARa mediates the transcriptional effects of drugs that induce peroxisome proliferation (29).”
BackgroundRevisiting PPARγ as a target for the treatment of metabolic disorders
Choi, S., Park, J., & Choi, J. H. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.11.174 · Cited by 154
Minireview: Nuclear Receptors and Breast Cancer
Conzen, S. D. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0421 · Cited by 162
“PPARs consist of a subfamily of three different isoforms: PPAR- , PPAR- , and PPAR- / , the ligands of which include long-chain polyunsaturated fatty acids, eicosanoid derivatives, and oxidized lipids (73).”
BackgroundEvaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate
Stroheker, T., Cabaton, N. J., Nourdin, G., Régnier, J.-F., Lhuguenot, J., & Chagnon, M. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.013 · Cited by 142
Jaeger, J. W., Carlson, I. H., & Porter, W. P. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500111 · Cited by 139
“Jacobson and Jacobson 1996a,b and Lonky et al. Ž .1996 present similar findings for children.”
Resultvan Roermund, C. W. T., Tabak, H. F., van den Berg, M., Wanders, R. J. A., & Hettema, E. H. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.3.489 · Cited by 141
“In vertebrates, peroxisomal proliferation has been shown to be regulated by peroxisomal proliferation activator receptors (PPAR) 1 , which are ligand-activated transcription factors (Issemann and Green, 1990; Dreyer et al., 1992; Lee et al., 1995).”
BackgroundA plurality of molecular targets: The receptor ecosystem for bisphenol-A (BPA)
MacKay, H., & Abizaid, A. B. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.11.001 · Cited by 156
“Subsequent study found that the PPARs are members of the highly conserved family of nuclear receptors to which the ERs, AR, and more also belong (Issemann and Green, 1990; Hong et al., 2014), and still later investigation revealed the existence of a number of PPAR subtypes (Youssef and Badr, 2013).”
Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes
Henke, B. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030631e · Cited by 147
Effect of Sesame Seeds Rich in Sesamin and Sesamolin on Fatty Acid Oxidation in Rat Liver
Yasumoto-Shirato, S., Katsuta, M., Okuyama, Y., Takahashi, Y., & Ide, T. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf001362t · Cited by 141
Surapureddi, S., Yu, S., Bu, H., Hashimoto, T., Yeldandi, A. V., Kashireddy, P., Cherkaoui-Malki, M., Qi, C., Zhu, Y.-J., Rao, M. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182426699 · Cited by 138
Polyunsaturated fatty acids inhibit S14 gene transcription in rat liver and cultured hepatocytes.
Jump, D. B., Clarke, S. D., MacDougald, O., & Thelen, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8454 · Cited by 142
Cook, J. C., Murray, S. M., Frame, S. R., & Hurtt, M. E. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90116-a · Cited by 140
Suchanek, K. M., May, F. J., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R., & Roberts‐Thomson, S. J. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10061 · Cited by 141
“PPARs are classified as belonging to the nuclear hormone receptor superfamily [1], which includes among its members the thyroid hormone receptor,”
BackgroundInfluentialBull, R. J. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s2241 · Cited by 152
David, R. M. (1999) · Toxicological Sciences · doi:10.1093/toxsci/50.2.195 · Cited by 140
“Therefore, it is still appropriate to use the threshold approach in calculating the no-significant-risk dose for human exposure to DEHP, in spite of evidence that the phenomenon of PP may be receptor mediated (Issemann and Green, 1990).”
BackgroundAntihyperglycemic and antidyslipidemic agent from Aegle marmelos
Narender, T., ., S., Tiwari, P., Reddy, K. P., Khaliq, T., Prathipati, P., Puri, A., Srivastava, A. K., Chander, R., Agarwal, S. C., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.037 · Cited by 162
Roberts, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.43 · Cited by 140
“PPARα is highly expressed in rodent liver and is activated by a diverse range of PPs ( 14 ).”
BackgroundMethodInfluentialRegulation of gene transcription by polyunsaturated fatty acids
Clarke, S. D., & Jump, D. Β. (1993) · Progress in Lipid Research · doi:10.1016/0163-7827(93)90013-m · Cited by 139
Lazar, M. A. (2004) · Biochimie · doi:10.1016/j.biochi.2004.10.021 · Cited by 156
Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15901 · Cited by 136
Peroxisome proliferator-activated receptor-$gamma; ligands as cell-cycle modulators
Theocharis, S., Margeli, A. P., Vielh, P. R., & Kouraklis, G. P. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.04.004 · Cited by 139
Fatehi-Hassanabad, Z., & Chan, C. B. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-1 · Cited by 135
Inoue, I., Shinoda, Y., Ikeda, M., Hayashi, K., Kanazawa, K., Nomura, M., Matsunaga, T., Xu, H., Kawai, S., Awata, T., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.169 · Cited by 135
Ibrahimi, A., Teboul, L., Gaillard, D., Amri, E. Z., Ailhaud, G., Young, P., Cawthorne, M. A., & Grimaldi, P. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09853-0 · Cited by 138
Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate
Rusyn, I., & Corton, J. C. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.004 · Cited by 129
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
Bellanti, F., Villani, R., Facciorusso, A., Vendemiale, G., & Serviddio, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.023 · Cited by 148
“PPARα induces genes involved in mitochondrial, peroxisomal, and microsomal FA oxidation [204-206].”
Structure and physiological functions of the human peroxisome proliferator-activated receptor γ
Zieleniak, A., Wójcik, M., & Woźniak, L. A. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0037-y · Cited by 149
“Three different human PPAR subtypes have been identified so far, designated as PPAR-α, PPAR-β (also known as PPAR-δ, or NUCI in humans, or FAAR in rodents), and PPAR-γ [29, 56].”
BackgroundDasgupta, C., Sakurai, R., Wang, Y., Guo, P., Ambalavanan, N., Torday, J. S., & Rehan, V. K. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90392.2008 · Cited by 137
“PPAR , a member of the steroid hormone receptor superfamily of ligand-activated transcription factors (18), in addition to being the key regulator of adipocyte differentiation, has a myriad of other effects, demonstrated both in vitro and in animal models (21, 36).”
BackgroundSertznig, P., Seifert, M., Tilgen, W., & Reichrath, J. (2008) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200809010-00002 · Cited by 151
Mammalian Stem Cells Reprogramming in Response to Terahertz Radiation
Bock, J., Fukuyo, Y., Kang, S., Phipps, M. L., Alexandrov, L. B., Rasmussen, K. Ø., Bishop, A. R., Rosen, E. D., Martinez, J. S., Chen, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015806 · Cited by 135
“No measurable changes were observed for the transcription factor alpha PPARA [24], TATA binding protein (TBP) [25], and cyclin B [26].”
BackgroundInfluentialLi, S., Nagothu, K. K., Desai, V. G., Lee, T., Branham, W. S., Moland, C. L., Megyesi, J. K., Crew, M. D., & Portilla, D. (2009) · Kidney International · doi:10.1038/ki.2009.330 · Cited by 142
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ
Zander, T., Kraus, J. A., Grommes, C., Schlegel, U., Feinstein, D., Klockgether, T., Landreth, G., Koenigsknecht, J., & Heneka, M. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00899.x · Cited by 135
“In contrast, incubation with the synthetic PPARa-agonist WY14643 (Issemann and Green 1990) did not affect cellular viability (Fig.”
BackgroundInfluentialFatty acids in cell signalling: Modulation by lipid binding proteins
Glatz, J. F. C., Börchers, T., Spener, F., & Vusse, G. J. (1995) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90010-1 · Cited by 135
Flavell, D. M., Jamshidi, Y., Hawe, E., Pineda Torra, I., Taskinen, M.-R., Frick, M. H., Nieminen, M. S., Kesäniemi, Y. A., Pasternack, A., Staels, B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000012145.80593.25 · Cited by 134
Fatty acid activation of peroxisome proliferator-activated receptor (PPAR)
Bocos, C., Göttlicher, M., Gearing, K. L., Banner, C. D., Enmark, E., Teboul, M., Crickmore, A., & Gustaffson, J.-Å. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00093-f · Cited by 134
The Role of PPARs in Lung Fibrosis
Lakatos, H. F., Thatcher, T. H., Kottmann, R. M., Garcia, T. M., Phipps, R. P., & Sime, P. J. (2007) · PPAR Research · doi:10.1155/2007/71323 · Cited by 139
“PPARα is found in high levels in liver, kidney, heart, and muscle, whereas PPARβ/δ is ubiquitously expressed [26, 27].”
BackgroundEffect of bezafibrate treatment on late-onset mitochondrial myopathy in mice
Yatsuga, S., & Suomalainen, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr482 · Cited by 124
Patel, H. J., Belvisi, M. G., Bishop‐Bailey, D., Yacoub, M. H., & Mitchell, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2663 · Cited by 139
“Peroxisome proliferator-activated receptors (PPARs) are a family of ligand-activated nuclear hormone receptors belonging to the steroid receptor superfamily (10, 11).”
BackgroundAntiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ali, F. Y., Armstrong, P. C. J., Dhanji, A., Tucker, A. T., Paul‐Clark, M. J., Mitchell, J. A., & Warner, T. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183160 · Cited by 143
Dietary polyunsaturated fatty acid regulation of gene transcription
Jump, D. Β., Clarke, S. D., Thelen, A. P., Liimatta, M. B., Ren, B., & Badin, M. V. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00007-0 · Cited by 153
Bogazzi, F., Hudson, L. D., & Nikodem, V. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32624-8 · Cited by 133
Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 138
Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
Chen, Y., Wu, J., Tsai, H.-D., Huang, C., Chen, J.-J., Sun, G. Y., & Lin, T. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8259-8 · Cited by 145
“was originally cloned from liver peroxisomes, organelles that participate in fatty acid metabolism [7].”
BackgroundOsteoporosis: the current status of mesenchymal stem cell-based therapy
Phetfong, J., Sanvoranart, T., Nartprayut, K., Nimsanor, N., Seenprachawong, K., Prachayasittikul, V., & Supokawej, A. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0013-1 · Cited by 136
“factor 2 (Runx2) and osterix (Osx) for osteoblasts and peroxisome proliferatoractivated receptor gamma (PPARγ) for adipocytes, suggesting an inverse correlation between osteogenesis and adipogenesis [15–19].”
PGC-1: The Energetic Regulator in Cardiac Metabolism
Di, W., Lv, J., Jiang, S., Lu, C., Yang, Z. P., Ma, Z., Hu, W., Yang, Y., & Xu, B. (2018) · Current Issues in Molecular Biology · doi:10.21775/cimb.028.029 · Cited by 137
Catalase Mediates Acetaldehyde Formation from Ethanol in Fetal and Neonatal Rat Brain
Hamby‐Mason, R., Chen, J. J., Schenker, S., Perez, A., & Henderson, G. I. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199709000-00020 · Cited by 131
Brown, P. J., Winegar, D. A., Plunket, K. D., Moore, L. B., Lewis, M. C., Wilson, J. G., Sundseth, S. S., Koble, C. S., Wu, Z., Chapman, J. M., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903601 · Cited by 128
Bishop‐Bailey, D., & Wray, J. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00003-0 · Cited by 151
Genetic Influences in Sport and Physical Performance
Puthucheary, Z., Skipworth, J. R. A., Rawal, J., Loosemore, M., van Someren, K. A., & Montgomery, H. (2011) · Sports Medicine · doi:10.2165/11593200-000000000-00000 · Cited by 165
“PPARa is a ligand-activated transcription factor.([122]) In addition to influences on muscle fibre type (see section 3.”
BackgroundPeroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation
Belvisi, M. G., Hele, D. J., & Birrell, M. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.048 · Cited by 141
Penas, F., Mirkin, G., Vera, M. S., Cevey, Á., Gonzalez, C., Gómez, M. I., Sales, M., & Goren, N. (2015) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2014.12.019 · Cited by 127
“PPARα was identified in the early 1990s as a target of hypolipidemic fibrate drugs and other compounds that induce peroxisome proliferation in rodents [10].”
BackgroundPeroxisome proliferator-activated receptor γ in malignant diseases
WANG, T., Xu, J., Yu, X., Yang, R., & Han, Z. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.011 · Cited by 154
Molecular genetics of the human cytochrome P450 monooxygenase superfamily
Smith, G. C., Stubbins, M. J., Harries, L. W., & Wolf, C. R. (1998) · Xenobiotica · doi:10.1080/004982598238868 · Cited by 146
Hays, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh285 · Cited by 130
Nutrigenomics: The Impact of Biomics Technology on Nutrition Research
Corthesy-Theulaz, I. E., den Dunnen, J. T., Ferré, P., Geurts, J. M. W., Müller, M. M., van Belzen, N., & van Ommen, B. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000088315 · Cited by 146
“PPARα was cloned as a murine nuclear receptor that mediates the effects of peroxisome proliferators [”
BackgroundButterworth, B. E., Conolly, R. B., & Morgan, K. T. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03794-w · Cited by 130
Muoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129
Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
Bishop-Bailey, D., & Bystrom, J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.011 · Cited by 118
“PPARα has since been cloned from xenopus, rats, guinea pigs and humans (Issemann & Green, 1990; Gottlicher et al., 1992; Dreyer et al., 1992; Sher et al, 1993; Mukherjee et al., 1994).”
MethodDalen, K. T., Ulven, S. M., Arntsen, B. M., Solaas, K., & Nebb, H. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500459-jlr200 · Cited by 125
“PPARa is enriched in liver and other metabolic tissues, such as muscle, heart, and kidney (30).”
In Vivo Actions of Peroxisome Proliferator–Activated Receptors
Eldor, R., DeFronzo, R. A., & Abdul-Ghani, M. (2013) · Diabetes Care · doi:10.2337/dcs13-2003 · Cited by 126
Sapone, A., Peters, J. M., Sakai, S., Tomita, S., Papiha, S. S., Dai, R., Friedman, F. K., & Gonzalez, F. J. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00006 · Cited by 130
Peroxisome proliferator-activated receptors in cutaneous biology
Kuenzli, S., & Saurat, J. ‐. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05532.x · Cited by 134
Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolism
Fruchart, J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02149-x · Cited by 138
Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial Cells
Nicholas, S. B., Kawano, Y., Wakino, S., Collins, A. R., & Hsueh, W. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.722 · Cited by 132
Marciano, D. P., Chang, M. R., Corzo, C. A., Goswami, D., Lam, V. Q., Pascal, B. D., & Griffin, P. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.009 · Cited by 140
“The precursor lead to the TZDs, 2-chloro-3-phenylpropanoic acid ethyl ester (AL-294), was discovered through in vivo screening efforts against insulin-resistant rodent models (Ikeda et al., 1981; Iwatsuka et al., 1970; Kawamatsu et al., 1980).”
BackgroundHeuvel, J. P. V. (1999) · Journal of Nutrition · doi:10.1093/jn/129.2.575s · Cited by 137
Canet, J. V., Dobón, A., & Tornero, P. (2012) · The Plant Cell · doi:10.1105/tpc.112.103028 · Cited by 139
“A similar function is performed by NHR-49 in C. elegans (Taubert et al., 2006) and by PPARa in vertebrates (Issemann and Green, 1990).”
BackgroundEdvardsson, U., Bergström, M., Alexandersson, M., Bamberg, K., Ljung, B., & Dahllöf, B. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33479-9 · Cited by 124
Regulation of apo A-I gene expression by fibrates
Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 135
“PPAR-a, which is predominantly expressed in tissues exhibiting high metabolic rates of fatty acids [8,12,13], plays an important role in lipoprotein metabolism as well as in the intracellular catabolism of fatty acids.”
BackgroundPPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Bastías‐Candia, S., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological Reviews · doi:10.1111/brv.12320 · Cited by 122
“PPARs were discovered in 1990, when I. Issemann and S. Green cloned a receptor that was activated by peroxisome proliferators (PPs) from a mouse liver genetic library (Lazarow & De Duve, 1976; Lock, Mitchell & Elcombe, 1989; Issemann & Green, 1990).”
MethodThe Roles of Xenobiotic Receptors: Beyond Chemical Disposition
Mackowiak, B., Hodge, J., Stern, S., & Wang, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081042 · Cited by 127
“family), and the peroxisome proliferator-activated receptors (Issemann and Green, 1990; Dreyer et al., 1992; Kliewer et al., 1998; Moore et al., 2000; Denison and Nagy, 2003; Wang and LeCluyse, 2003).”
BackgroundSierra, M. L., Bénéton, V., Boullay, A.-B., Boyer, T., Brewster, A. G., Donche, F., Forest, M.-C., Fouchet, M.-H., Gellibert, F. J., Grillot, D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm058056x · Cited by 135
Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors
Clarke, S. D., Thuillier, P., Baillie, R., & Sha, X. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.4.566 · Cited by 138
Göttlicher, M., Demoz, A., Svensson, D., Tollet, P., Berge, R. K., & Gustafsson, J.-Α. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90607-x · Cited by 123
Simon, T. C., Roth, K. A., & Gordon, J. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46851-7 · Cited by 128
PPAR and Immune System-What Do We Know?
Zhang, X., & Young, H. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00057-7 · Cited by 123
“Greene ME, Blumberg B, McBride OW, Yi HE, Kronquist K, Hsieh L, et al. Isolation of the human peroxisome proliferator activated receptor γ cDNA: expression in hematopoietic cells and chromosomal mapping.”
BackgroundInfluentialMellor, C. L., Steinmetz, F. P., & Cronin, M. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2015.1089471 · Cited by 127
Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis
Ockner, R. K., Kaikaus, R. M., & Bass, N. M. (1993) · Hepatology · doi:10.1002/hep.1840180327 · Cited by 121
The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor
Issemann, I., Prince, R. A., Tugwood, J. D., & Green, S. (1993) · Biochimie · doi:10.1016/0300-9084(93)90084-6 · Cited by 134
Self-citationBe different—The diversity of peroxisomes in the animal kingdom
Islinger, M., Cardoso, M. J., & Schrader, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.03.013 · Cited by 136
Palli, S. R., Hiruma, K., & Riddiford, L. M. (1992) · Developmental Biology · doi:10.1016/0012-1606(92)90244-b · Cited by 125
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 118
“metabolism [7] as well as sustaining the balance between energy production and utilization in tissues with a high oxidative capacity, such as the liver, kidney and heart [8].”
BackgroundPPARδ, but not PPARα, activates PGC-1α gene transcription in muscle
Hondares, E., Pineda-Torra, I., Iglesias, R., Staels, B., Villarroya, F., & Giralt, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.092 · Cited by 120
Peroxisome Proliferator-Activated Receptor-α Enhances Lipid Metabolism in a Skin Equivalent Model
Rivier, M., Safonova, I., Michel, S., Castiel, I., & Ailhaud, G. P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00939.x · Cited by 127
Implications for Risk Assessment of Suggested Nongenotoxic Mechanisms of Chemical Carcinogenesis
Melnick, R. L., Kohn, M. C., & Portier, C. J. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s1123 · Cited by 132
PPAR influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
Nicol, C. J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh160 · Cited by 120
Duez, H., Lefebvre, B., Poulain, P., Torra, I. P., Percevault, F., Luc, G., Peters, J. M., Gonzalez, F. J., Gineste, R., Helleboid, S., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154140.73570.00 · Cited by 120
Metadata
- Authors
- Issemann, I., & Green, S.
- Venue
- Nature
- Published
- 1990-10
- Volume
- 347
- Issue
- 6294
- Pages
- 645-650
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066092624
- Cited by
- 3,519
- References
- 56
- Citations by year
- 2026: 38 · 2025: 59 · 2024: 60 · 2023: 47 · 2022: 58 · 2021: 71 · 2020: 63 · 2019: 82 · 2018: 74 · 2017: 90 · 2016: 87 · 2015: 94 · 2014: 98 · 2013: 106 · 2012: 133
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- peroxisome proliferator-activated receptors, steroid hormone receptors, ligand-activated transcription factors, peroxisome proliferation, hepatocarcinogens, hypolipidemic effect, cancer risk, receptor cloning
- MeSH terms
- Amino Acid Sequence, Animals, Hypolipidemic Agents, Base Sequence, Binding Sites, Cloning, Molecular, DNA, Humans, Liver, Liver Neoplasms, Experimental, Microbodies, Molecular Sequence Data, Nafenopin, Receptors, Estrogen, Receptors, Glucocorticoid, Receptors, Steroid, Sequence Homology, Nucleic Acid, Tissue Distribution, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.